BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3922229)

  • 1. Dihydropyridine Ca2+ antagonists: potent inhibitors of secretion from normal and transformed pituitary cells.
    Enyeart JJ; Aizawa T; Hinkle PM
    Am J Physiol; 1985 May; 248(5 Pt 1):C510-9. PubMed ID: 3922229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of dihydropyridine Ca2+ agonist Bay K 8644 with normal and transformed pituitary cells.
    Enyeart JJ; Aizawa T; Hinkle PM
    Am J Physiol; 1986 Jan; 250(1 Pt 1):C95-102. PubMed ID: 2417496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary Ca2+ channels: blockade by conventional and novel Ca2+ antagonists.
    Enyeart JJ; Sheu SS; Hinkle PM
    Am J Physiol; 1987 Jul; 253(1 Pt 1):C162-70. PubMed ID: 2440312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 45Ca2+ uptake into rat whole brain synaptosomes unaltered by dihydropyridine calcium antagonists.
    Daniell LC; Barr EM; Leslie SW
    J Neurochem; 1983 Nov; 41(5):1455-9. PubMed ID: 6619877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor affects cytosolic free calcium concentration and prolactin secretion in GH4C1 rat pituitary cells.
    Yang JP; Tashjian AH
    Biochem Biophys Res Commun; 1991 Jan; 174(2):424-31. PubMed ID: 1847044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calcium agonist Bay K 8644 stimulates secretion from a pituitary cell line.
    Enyeart JJ; Hinkle PM
    Biochem Biophys Res Commun; 1984 Aug; 122(3):991-6. PubMed ID: 6206857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
    Day RN; Hinkle PM
    Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25-Dihydroxycholecalciferol enhances both the bombesin-induced transient in intracellular free Ca2+ and the bombesin-induced secretion of prolactin in GH4C1 pituitary cells.
    Törnquist K
    Endocrinology; 1991 Apr; 128(4):2175-82. PubMed ID: 1900787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes.
    Carvalho CA; Coutinho OP; Carvalho AP
    J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyridine modulators of voltage-sensitive Ca2+ channels specifically regulate prolactin production by GH4C1 pituitary tumor cells.
    Enyeart JJ; Sheu SS; Hinkle PM
    J Biol Chem; 1987 Mar; 262(7):3154-9. PubMed ID: 2434497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing actions of Bay K 8644 enantiomers on calcium current, prolactin secretion, and synthesis in pituitary cells.
    Enyeart JJ; Biagi B; Day RN
    Mol Endocrinol; 1990 May; 4(5):727-35. PubMed ID: 1703274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine inhibits prolactin and growth hormone secretion in a clonal pituitary cell line.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1985 Dec; 117(6):2330-8. PubMed ID: 2998734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+ channel agonists enhance thyrotropin-releasing hormone-induced inositol phosphates and prolactin secretion.
    Pachter JA; Law GJ; Dannies PS
    Eur J Pharmacol; 1991 Apr; 195(3):373-9. PubMed ID: 1714395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voltage-dependent calcium channels in pituitary cells in culture. II. Participation in thyrotropin-releasing hormone action on prolactin release.
    Tan KN; Tashjian AH
    J Biol Chem; 1984 Jan; 259(1):427-34. PubMed ID: 6323410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maitotoxin induces a calcium-dependent membrane depolarization in GH4C1 pituitary cells via activation of type L voltage-dependent calcium channels.
    Xi D; Van Dolah FM; Ramsdell JS
    J Biol Chem; 1992 Dec; 267(35):25025-31. PubMed ID: 1334077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium hyposmolarity stimulates prolactin secretion in GH4C1 cells by inducing an increase in cytosolic free calcium.
    Sato N; Wang XB; Greer MA; Greer SE; McAdams S; Oshima T
    Endocrinology; 1990 Aug; 127(2):957-64. PubMed ID: 2373063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
    Aizawa T; Hinkle PM
    Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of thyrotropin-releasing hormone-induced spike and plateau phases in cytosolic free Ca2+ concentrations to hormone secretion. Selective blockade using ionomycin and nifedipine.
    Albert PR; Tashjian AH
    J Biol Chem; 1984 Dec; 259(24):15350-63. PubMed ID: 6439720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.